✦ LIBER ✦

A Phase II Trial of FOLFOX6 and Cetuximab in the First-line Treatment of Patients With Metastatic Colorectal Cancer

✍ Scribed by Ralph V. Boccia; Thomas M. Cosgriff; David L. Headley; Suprith Badarinath; Shaker R. Dakhil

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FOLFOX4 With Cetuximab vs. UFOX With Cet

✍ Douillard, Jean-Yves; Zemelka, Tomasz; Fountzilas, George; Barone, Carlo; Schlic 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 454 KB

A multicenter phase II study of the stop

✍ Natsuko T. Okita, Taito Esaki, Eishi Baba, Daisuke Sakai, Shinya Tokunaga, Hiroy 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 174 KB

3046 POSTER A randomized, open-label pha

✍ T.E. Ciuleanu; W. Scheithauer; G. Kurteva; J. Ocvirk; I. Koza; D. Papamichael; M 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 55 KB

PCN3 Cetuximab for the First-Line Treatm

✍ Ubago, R.; Castillo, M.A.; Flores, S.; Rodriguez, R.; Beltran, C. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Results of a Phase II Trial of Cetuximab

✍ Thomas Cartwright; Paul Kuefler; Allen Cohn; William Hyman; Maury Berger; Donald 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 144 KB

Phase III Trial of FOLFOX plus Bevacizum

✍ Jane D. Robertson; Nick A. Botwood; Mace L. Rothenberg; Hans-Joachim Schmoll 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 77 KB